Oralia Barboza‐Quintana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Oralia Barboza‐Quintana has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Cuellar‐Barboza
Department of Dermatology, Hospital Universitario “Dr. José E. González” Universidad Autonoma de Nuevo León Monterrey México
2 shared publications - Barbara Saenz-Ibarra
Anatomic and Clinical Pathology Department, Hospital Universitario ‘Dr. José Eleuterio González’ Universidad Autónoma de Nuevo León Monterrey Mexico
2 shared publications - Jesus Alberto Cardenas-De la Garza
Rheumatology Department, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México
2 shared publications - Jorge Ocampo-Candiani
Department of Dermatology, Hospital Universitario “Dr. José Eleuterio González” Universidad Autónoma de Nuevo León Monterrey México
2 shared publications - Oliverio Welsh
Department of Dermatology Hospital Universitario “José Eleuterio González” Universidad Autónoma de Nuevo León Monterrey Mexico
2 shared publications - Raquel Garza-Guajardo
Universidad Autonóma de Nuevo León
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Pathology
- Vol. 2025 (1)
Primary Intracranial Sarcomatoid Yolk Sac Tumor With Unique Histology: A Case Report
Primary intracranial pure yolk sac tumors (YSTs) are rare, and their typical histological findings have been documented in the literature. We report a case of a 20‐year‐old young man with an intra‐axial primary YST exhibiting a unique sarcomatoid morphology. This case demonstrates that primary intracranial YSTs present uncommon patterns underscoring the importance of including YSTs in the differential diagnosis of midline masses. To the best of our knowledge, this is the first reported pure primary intracranial YST showing sarcomatoid histology.
- 1 January 2025
- Published by Wiley in Case Reports in Pathology
- Vol. 2025 (1)
Open AccessPrimary Intracranial Sarcomatoid Yolk Sac Tumor With Unique Histology: A Case Report
Primary intracranial pure yolk sac tumors (YSTs) are rare, and their typical histological findings have been documented in the literature. We report a case of a 20‐year‐old young man with an intra‐axial primary YST exhibiting a unique sarcomatoid morphology. This case demonstrates that primary intracranial YSTs present uncommon patterns underscoring the importance of including YSTs in the differential diagnosis of midline masses. To the best of our knowledge, this is the first reported pure primary intracranial YST showing sarcomatoid histology.
- 1 March 2020
- Published by Wiley in Experimental Dermatology
- Vol. 29 (3) , 259-264
Local secretion of stress hormones increases in alopecia areata lesions after treatment with UVA-1 phototherapy
Alopecia areata (AA) is an autoimmune disease of the hair follicle. Keratinocytes of the hair follicle generate an immunosuppressive environment by the local secretion of hormones of the hypothalamic-pituitary-adrenal axis of the skin (skin HPA analog). Our objective was to measure the local production of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and alpha-melanocyte-stimulating hormone (alpha-MSH) in the scalp tissue of patients with AA before and after ultraviolet A1 (UVA-1) phototherapy to determine their role in the pathogenesis of AA and the effect of UVA-1 on the AA hormonal environment. This was a retrospective and descriptive study of skin samples from 22 patients with AA before and after UVA-1 treatment. We compared the changes in the local hormonal environment by measuring CRH, ACTH, type 2 melanocortin receptor (ACTH receptor) and alpha-MSH with immunohistochemical stains. The positivity of MSH was significantly higher (P = .037) in the post-treatment samples compared with the baseline value. ACTH was significantly higher in intensity (P = .032) in the post-treatment samples compared with the initial value. CRH was significantly higher in intensity (P = .013) in baseline samples compared with the final biopsies. The positivity of the ACTH receptor MC2R was not different between the two groups (P = .626). In AA, an interruption in the signalling of CRH could decrease the local concentration of ACTH and MSH, and consequently, the immunosuppressive effect of these hormones. This phenomenon is normalized in the skin treated with UVA-1. A defective signalling system in the cutaneous HPA axis may be involved in the pathogenesis of AA.
- 1 March 2020
- Published by Wiley in Experimental Dermatology
- Vol. 29 (3) , 259-264
Local secretion of stress hormones increases in alopecia areata lesions after treatment with UVA-1 phototherapy
Alopecia areata (AA) is an autoimmune disease of the hair follicle. Keratinocytes of the hair follicle generate an immunosuppressive environment by the local secretion of hormones of the hypothalamic-pituitary-adrenal axis of the skin (skin HPA analog). Our objective was to measure the local production of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and alpha-melanocyte-stimulating hormone (alpha-MSH) in the scalp tissue of patients with AA before and after ultraviolet A1 (UVA-1) phototherapy to determine their role in the pathogenesis of AA and the effect of UVA-1 on the AA hormonal environment. This was a retrospective and descriptive study of skin samples from 22 patients with AA before and after UVA-1 treatment. We compared the changes in the local hormonal environment by measuring CRH, ACTH, type 2 melanocortin receptor (ACTH receptor) and alpha-MSH with immunohistochemical stains. The positivity of MSH was significantly higher (P = .037) in the post-treatment samples compared with the baseline value. ACTH was significantly higher in intensity (P = .032) in the post-treatment samples compared with the initial value. CRH was significantly higher in intensity (P = .013) in baseline samples compared with the final biopsies. The positivity of the ACTH receptor MC2R was not different between the two groups (P = .626). In AA, an interruption in the signalling of CRH could decrease the local concentration of ACTH and MSH, and consequently, the immunosuppressive effect of these hormones. This phenomenon is normalized in the skin treated with UVA-1. A defective signalling system in the cutaneous HPA axis may be involved in the pathogenesis of AA.
- Open Access
- 8 August 2019
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 7 (9) , e931
Phenotypic severity in a family with MEND syndrome is directly associated with the accumulation of potentially functional variants of cholesterol homeostasis genes
Background: Male EBP disorder with neurologic defects (MEND) syndrome is an X‐linked disease caused by hypomorphic mutations in the EBP (emopamil‐binding protein) gene. Modifier genes may explain the clinical variability among individuals who share a primary mutation.Methods: We studied four males (Patient 1 to Patient 4) exhibiting a descending degree of phenotypic severity from a family with MEND syndrome. To identify candidate modifier genes that explain the phenotypic variability, variants of homeostasis cholesterol genes identified by whole‐exome sequencing (WES) were ranked according to the predicted magnitude of their effect through an in‐house scoring system.Results: Twenty‐seven from 105 missense variants found in 45 genes of the four exomes were considered significant (−5 to −9 scores). We found a direct genotype–phenotype association based on the differential accumulation of potentially functional gene variants among males. Patient 1 exhibited 17 variants, both Patients 2 and 3 exhibited nine variants, and Patient 4 exhibited only five variants.Conclusion: We conclude that APOA5 (rs3135506), ABCA1 (rs9282541), and APOB (rs679899 and rs12714225) are the most relevant candidate modifier genes in this family. Relative accumulation of the deficiencies associated with variants of these genes along with other lesser deficiencies in other genes appears to explain the variable expressivity in MEND syndrome.
- 8 August 2019
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 7 (9) , e931
Open AccessPhenotypic severity in a family with MEND syndrome is directly associated with the accumulation of potentially functional variants of cholesterol homeostasis genes
Background: Male EBP disorder with neurologic defects (MEND) syndrome is an X‐linked disease caused by hypomorphic mutations in the EBP (emopamil‐binding protein) gene. Modifier genes may explain the clinical variability among individuals who share a primary mutation.Methods: We studied four males (Patient 1 to Patient 4) exhibiting a descending degree of phenotypic severity from a family with MEND syndrome. To identify candidate modifier genes that explain the phenotypic variability, variants of homeostasis cholesterol genes identified by whole‐exome sequencing (WES) were ranked according to the predicted magnitude of their effect through an in‐house scoring system.Results: Twenty‐seven from 105 missense variants found in 45 genes of the four exomes were considered significant (−5 to −9 scores). We found a direct genotype–phenotype association based on the differential accumulation of potentially functional gene variants among males. Patient 1 exhibited 17 variants, both Patients 2 and 3 exhibited nine variants, and Patient 4 exhibited only five variants.Conclusion: We conclude that APOA5 (rs3135506), ABCA1 (rs9282541), and APOB (rs679899 and rs12714225) are the most relevant candidate modifier genes in this family. Relative accumulation of the deficiencies associated with variants of these genes along with other lesser deficiencies in other genes appears to explain the variable expressivity in MEND syndrome.
- 8 October 2018
- Published by Wiley in The Journal of Dermatology
- Vol. 46 (4) , E128-E129
Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia
- 8 October 2018
- Published by Wiley in The Journal of Dermatology
- Vol. 46 (4) , E128-E129
Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia